{"id":4060,"date":"2018-05-16T21:47:33","date_gmt":"2018-05-16T21:47:33","guid":{"rendered":"https:\/\/www.progeriaresearch.org\/?p=4060"},"modified":"2020-12-13T18:14:09","modified_gmt":"2020-12-13T23:14:09","slug":"eiger-press-release-2","status":"publish","type":"post","link":"https:\/\/www.progeriaresearch.org\/ar\/2018\/05\/16\/eiger-press-release-2\/","title":{"rendered":"\u0641\u064a \u0623\u0639\u0642\u0627\u0628 \u062f\u0631\u0627\u0633\u0629 JAMA\u060c \u062a\u062a\u0639\u0627\u0648\u0646 PRF \u0648Eiger BioPharmaceuticals \u0644\u0644\u062d\u0635\u0648\u0644 \u0639\u0644\u0649 \u0645\u0648\u0627\u0641\u0642\u0629 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 \u0639\u0644\u0649 \u0639\u0642\u0627\u0631 Lonafarnib"},"content":{"rendered":"<p>[et_pb_section fb_built=&quot;1&quot; _builder_version=&quot;3.22&quot;][et_pb_row _builder_version=&quot;3.25&quot; background_size=&quot;initial&quot; background_position=&quot;top_left&quot; background_repeat=&quot;repeat&quot;][et_pb_column type=&quot;4_4&quot; _builder_version=&quot;3.25&quot; custom_padding=&quot;|||&quot; custom_padding__hover=&quot;|||&quot;][et_pb_text _builder_version=&quot;4.6.5&quot; background_size=&quot;initial&quot; background_position=&quot;top_left&quot; background_repeat=&quot;repeat&quot; hover_enabled=&quot;0&quot; sticky_enabled=&quot;0&quot;]<\/p>\n<p>\u064a\u0645\u062b\u0644 \u0647\u0630\u0627 \u0627\u0644\u062a\u0639\u0627\u0648\u0646 \u0623\u0648\u0644 \u0628\u062d\u062b \u0644\u0639\u0644\u0627\u062c \u0645\u0631\u0636 \u0627\u0644\u0634\u064a\u062e\u0648\u062e\u0629 \u0627\u0644\u0645\u0628\u0643\u0631\u0629. \u0648\u0641\u064a \u062d\u0627\u0644\u0629 \u0627\u0644\u0645\u0648\u0627\u0641\u0642\u0629 \u0639\u0644\u064a\u0647\u060c \u064a\u0645\u0643\u0646 \u0644\u0644\u0623\u0637\u0641\u0627\u0644 \u0627\u0644\u062d\u0635\u0648\u0644 \u0639\u0644\u0649 \u0627\u0644\u062f\u0648\u0627\u0621 \u0628\u0648\u0635\u0641\u0629 \u0637\u0628\u064a\u0629 \u0628\u062f\u0644\u0627\u064b \u0645\u0646 \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629!!<\/p>\n<p>\u0627\u0642\u0631\u0623 \u0623\u062d\u062f\u062b \u0628\u064a\u0627\u0646\u0627\u062a\u0646\u0627 \u0627\u0644\u0635\u062d\u0641\u064a\u0629 \u0647\u0646\u0627:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/PRF-Eiger-FINAL-Press-release.pdf\">\u0645\u0624\u0633\u0633\u0629 \u0623\u0628\u062d\u0627\u062b \u0645\u0631\u0636 \u0628\u0631\u0648\u062c\u064a\u0631\u064a\u0627 \u062a\u0639\u0644\u0646 \u0639\u0646 \u0627\u062a\u0641\u0627\u0642\u064a\u0629 \u062a\u0639\u0627\u0648\u0646 \u0648\u062a\u0648\u0631\u064a\u062f \u0645\u0639 \u0634\u0631\u0643\u0629 \u0625\u064a\u062c\u0631 \u0628\u064a\u0648\u0641\u0627\u0631\u0645\u0627\u0633\u064a\u0648\u062a\u064a\u0643\u0627\u0644\u0632\u00a0<\/a><\/li>\n<li><a href=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/04\/PRF-JAMA-Announcement_Press-Release-1.pdf\">\u062f\u0631\u0627\u0633\u0629 \u0639\u0627\u0644\u0645\u064a\u0629 \u0646\u064f\u0634\u0631\u062a \u0641\u064a \u0645\u062c\u0644\u0629 \u0627\u0644\u062c\u0645\u0639\u064a\u0629 \u0627\u0644\u0637\u0628\u064a\u0629 \u0627\u0644\u0623\u0645\u064a\u0631\u0643\u064a\u0629 (JAMA) \u062a\u062c\u062f \u0623\u0646 \u0627\u0644\u0639\u0644\u0627\u062c \u0628\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0644\u0648\u0646\u0627\u0641\u0627\u0631\u0646\u064a\u0628 \u064a\u0637\u064a\u0644 \u0641\u062a\u0631\u0629 \u0627\u0644\u0628\u0642\u0627\u0621 \u0639\u0644\u0649 \u0642\u064a\u062f \u0627\u0644\u062d\u064a\u0627\u0629 \u0644\u062f\u0649 \u0627\u0644\u0623\u0637\u0641\u0627\u0644 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0627\u0644\u0634\u064a\u062e\u0648\u062e\u0629 \u0627\u0644\u0645\u0628\u0643\u0631\u0629<\/a><\/li>\n<\/ul>\n<div id=\"attachment_9151\" style=\"width: 285px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-9151\" class=\"size-medium wp-image-9151\" src=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/12\/getting-drug-zoeycarly-April-2016-1-275x300.jpg\" alt=\"\" width=\"275\" height=\"300\" \/><p id=\"caption-attachment-9151\" class=\"wp-caption-text\">\u0632\u0648\u064a \u0648\u0643\u0627\u0631\u0644\u064a \u062a\u062a\u0644\u0642\u0649\u0627\u0646 \u0627\u0644\u0639\u0644\u0627\u062c \u0628\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0644\u0648\u0646\u0627\u0641\u0627\u0631\u0646\u064a\u0628 \u062e\u0644\u0627\u0644 \u0632\u064a\u0627\u0631\u062a\u0647\u0645\u0627 \u0627\u0644\u0623\u062e\u064a\u0631\u0629 \u0644\u0644\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0641\u064a \u0628\u0648\u0633\u0637\u0646.<\/p><\/div>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>\u0641\u064a \u0623\u0639\u0642\u0627\u0628 \u062f\u0631\u0627\u0633\u0629 JAMA\u060c \u062a\u062a\u0639\u0627\u0648\u0646 PRF \u0648Eiger BioPharmaceuticals \u0644\u0644\u062d\u0635\u0648\u0644 \u0639\u0644\u0649 \u0645\u0648\u0627\u0641\u0642\u0629 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0639\u0644\u0649 \u0639\u0642\u0627\u0631 Lonafarnib. \t<\/p>","protected":false},"author":2,"featured_media":11817,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<p>Collaboration marks the first submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial!!<\/p><p>Read our latest press releases here:<\/p><ul><li><a href=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/PRF-Eiger-FINAL-Press-release.pdf\">Progeria Research Foundation Announces Collaboration and Supply Agreement with Eiger BioPharmaceuticals\u00a0<\/a><\/li><li><a href=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/04\/PRF-JAMA-Announcement_Press-Release-1.pdf\">Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria<\/a><\/li><\/ul>[caption id=\"attachment_9151\" align=\"aligncenter\" width=\"275\"]<img class=\"size-medium wp-image-9151\" src=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/12\/getting-drug-zoeycarly-April-2016-1-275x300.jpg\" alt=\"\" width=\"275\" height=\"300\" \/> Zoey and Carly getting their lonafarnib treatment during their latest clinical trial visit to Boston.[\/caption]<p>\u00a0<\/p>","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[],"class_list":["post-4060","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-news","post_format-post-format-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib - The Progeria Research Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.progeriaresearch.org\/ar\/2018\/05\/16\/eiger-press-release-2\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib - The Progeria Research Foundation\" \/>\n<meta property=\"og:description\" content=\"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.progeriaresearch.org\/ar\/2018\/05\/16\/eiger-press-release-2\/\" \/>\n<meta property=\"og:site_name\" content=\"The Progeria Research Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ProgeriaResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-16T21:47:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-13T23:14:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"225\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karen Betournay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Progeria\" \/>\n<meta name=\"twitter:site\" content=\"@Progeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karen Betournay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/\"},\"author\":{\"name\":\"Karen Betournay\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946\"},\"headline\":\"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib\",\"datePublished\":\"2018-05-16T21:47:33+00:00\",\"dateModified\":\"2020-12-13T23:14:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/\"},\"wordCount\":159,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/\",\"url\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/\",\"name\":\"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib - The Progeria Research Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg\",\"datePublished\":\"2018-05-16T21:47:33+00:00\",\"dateModified\":\"2020-12-13T23:14:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#primaryimage\",\"url\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg\",\"contentUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg\",\"width\":300,\"height\":225},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.progeriaresearch.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#website\",\"url\":\"https:\/\/www.progeriaresearch.org\/ta\/\",\"name\":\"The Progeria Research Foundation\",\"description\":\"For the Children \u2665 For the Cure\",\"publisher\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.progeriaresearch.org\/ta\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#organization\",\"name\":\"The Progeria Research Foundation\",\"url\":\"https:\/\/www.progeriaresearch.org\/ta\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png\",\"contentUrl\":\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png\",\"width\":300,\"height\":86,\"caption\":\"The Progeria Research Foundation\"},\"image\":{\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ProgeriaResearch\/\",\"https:\/\/x.com\/Progeria\",\"https:\/\/www.instagram.com\/progeriaresearch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946\",\"name\":\"Karen Betournay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"caption\":\"Karen Betournay\"},\"url\":\"https:\/\/www.progeriaresearch.org\/ar\/author\/karenb\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib - The Progeria Research Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.progeriaresearch.org\/ar\/2018\/05\/16\/eiger-press-release-2\/","og_locale":"ar_AR","og_type":"article","og_title":"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib - The Progeria Research Foundation","og_description":"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib.","og_url":"https:\/\/www.progeriaresearch.org\/ar\/2018\/05\/16\/eiger-press-release-2\/","og_site_name":"The Progeria Research Foundation","article_publisher":"https:\/\/www.facebook.com\/ProgeriaResearch\/","article_published_time":"2018-05-16T21:47:33+00:00","article_modified_time":"2020-12-13T23:14:09+00:00","og_image":[{"width":300,"height":225,"url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg","type":"image\/jpeg"}],"author":"Karen Betournay","twitter_card":"summary_large_image","twitter_creator":"@Progeria","twitter_site":"@Progeria","twitter_misc":{"Written by":"Karen Betournay","Est. reading time":"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#article","isPartOf":{"@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/"},"author":{"name":"Karen Betournay","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946"},"headline":"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib","datePublished":"2018-05-16T21:47:33+00:00","dateModified":"2020-12-13T23:14:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/"},"wordCount":159,"commentCount":0,"publisher":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg","articleSection":["News"],"inLanguage":"ar","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/","url":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/","name":"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib - The Progeria Research Foundation","isPartOf":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#primaryimage"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg","datePublished":"2018-05-16T21:47:33+00:00","dateModified":"2020-12-13T23:14:09+00:00","breadcrumb":{"@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#primaryimage","url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg","contentUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2018\/05\/getting-drug-zoeycarly-April-2016-300x225-1.jpg","width":300,"height":225},{"@type":"BreadcrumbList","@id":"https:\/\/www.progeriaresearch.org\/nl\/2018\/05\/16\/eiger-press-release-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.progeriaresearch.org\/"},{"@type":"ListItem","position":2,"name":"On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib"}]},{"@type":"WebSite","@id":"https:\/\/www.progeriaresearch.org\/ta\/#website","url":"https:\/\/www.progeriaresearch.org\/ta\/","name":"\u0645\u0624\u0633\u0633\u0629 \u0623\u0628\u062d\u0627\u062b \u0645\u0631\u0636 \u0627\u0644\u0634\u064a\u062e\u0648\u062e\u0629 \u0627\u0644\u0645\u0628\u0643\u0631\u0629","description":"\u0645\u0646 \u0623\u062c\u0644 \u0627\u0644\u0623\u0637\u0641\u0627\u0644 \u2665 \u0645\u0646 \u0623\u062c\u0644 \u0627\u0644\u0639\u0644\u0627\u062c","publisher":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.progeriaresearch.org\/ta\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization","name":"\u0645\u0624\u0633\u0633\u0629 \u0623\u0628\u062d\u0627\u062b \u0645\u0631\u0636 \u0627\u0644\u0634\u064a\u062e\u0648\u062e\u0629 \u0627\u0644\u0645\u0628\u0643\u0631\u0629","url":"https:\/\/www.progeriaresearch.org\/ta\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/","url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png","contentUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png","width":300,"height":86,"caption":"The Progeria Research Foundation"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ProgeriaResearch\/","https:\/\/x.com\/Progeria","https:\/\/www.instagram.com\/progeriaresearch\/"]},{"@type":"Person","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946","name":"\u0643\u0627\u0631\u064a\u0646 \u0628\u064a\u062a\u0648\u0631\u0646\u0627\u064a","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","caption":"Karen Betournay"},"url":"https:\/\/www.progeriaresearch.org\/ar\/author\/karenb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/posts\/4060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/comments?post=4060"}],"version-history":[{"count":0,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/posts\/4060\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/media\/11817"}],"wp:attachment":[{"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/media?parent=4060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/categories?post=4060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/tags?post=4060"}],"curies":[{"name":"\u0648\u0648\u0631\u062f\u0628\u0631\u064a\u0633","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}